March 8, 2018 / 8:14 AM / 4 months ago

BRIEF-Glaxosmithkline Says Updated Marketing Authorisation By European Commission Will Be Reflected In Label For Relvar Ellipta

March 8 (Reuters) - Glaxosmithkline Plc:

* UPDATED MARKETING AUTHORISATION BY EUROPEAN COMMISSION WILL BE REFLECTED IN LABEL FOR RELVAR ELLIPTA FOR COUNTRIES IN EUROPEAN UNION​ Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below